Artificial Intelligence, Healthcare and Renewable energy – Three investment sectors for the rest of 2024 – Investing Abroad News

By Nigel Green

Moving into the second half of 2024, investors are looking ahead and rebalancing their portfolios. While the market remains unpredictable, certain sectors exhibit promising growth potential driven by technological advancements, societal shifts, and economic policies.

Here, I’ll delve into three sectors I’m eyeing for the rest of the year.

Renewable energy

The transition from fossil fuels to cleaner energy sources is not just a trend but a necessity driven by climate change imperatives and governmental policies. This shift is underpinned by significant technological advancements, making renewable energy more efficient and cost-effective.

Governments worldwide are ramping up their commitments to reduce carbon emissions. The United States, for instance, has introduced substantial tax credits and incentives for renewable energy projects through the Inflation Reduction Act.

Similarly, the European Union’s Green Deal aims to make Europe the first climate-neutral continent by 2050, with massive investments in renewable infrastructure.

Innovation in renewable technologies, particularly solar and wind, has drastically reduced costs.

Solar photovoltaic (PV) technology continues to improve in efficiency while decreasing in price, making it more accessible and scalable. Wind power, especially offshore wind, is also seeing rapid advancements in turbine technology, enhancing its viability.

Also, corporations are increasingly committing to sustainability goals, driving demand for renewable energy. Companies like Google and Apple are not only pledging to use 100% renewable energy but are also investing in renewable energy projects, further fuelling the sector’s growth.

Investing in renewable energy companies or ETFs that focus on clean energy can provide long-term gains as the world continues to pivot toward sustainable energy solutions.

Artificial Intelligence

Artificial Intelligence (AI) has transitioned from a niche technology to a central component of modern business and daily life. Its applications span numerous industries, promising to revolutionize everything from healthcare to finance.

Much of this, of course, has been driven by Nvidia, the chip maker, which is the top performer in 2024 of all companies in the US, with a scorching 132% year-to-date return to date.

AI is being integrated into various sectors to enhance efficiency, productivity, and customer experience. In finance, AI algorithms are revolutionizing trading, risk management, and fraud detection. In retail, AI-driven analytics are optimizing supply chains and personalizing customer interactions.

The tech’s role in healthcare is also expanding rapidly, with applications in diagnostics, personalized medicine, and operational efficiency.

Machine learning algorithms are now capable of analyzing medical images with remarkable accuracy, assisting in early disease detection. Personalized treatment plans based on AI analysis of patient data are becoming more common, improving outcomes and reducing costs.

The surge in venture capital funding for AI startups indicates strong confidence in the sector’s potential.

These startups are pushing the boundaries of what this tech can achieve, from autonomous vehicles to advanced robotics, presenting numerous investment opportunities.

Healthcare

The healthcare sector has always been a robust investment avenue, given its essential nature. However, recent innovations and demographic trends make it particularly attractive for the rest of 2024.

The global population is aging, particularly in developed countries.

This demographic shift is increasing demand for healthcare services, pharmaceuticals, and medical devices. Companies that cater to age-related healthcare needs, such as those specializing in chronic disease management and elder care, are poised for growth.

Advancements in biotech and pharmaceuticals are creating new treatments and therapies. Innovations such as CRISPR gene editing and personalized medicine are not only improving patient outcomes but are also opening up lucrative markets.

The intersection of technology and healthcare, often referred to as health tech, is another burgeoning area. Telemedicine, which saw explosive growth during the pandemic, continues to expand as patients and providers appreciate its convenience and efficiency.

Wearable health devices and remote monitoring tools are also gaining traction, providing continuous health data that can lead to better patient outcomes and more efficient care management.

Governments and private sectors are increasing their investment in healthcare infrastructure and innovation. Policies aimed at expanding healthcare access and improving healthcare outcomes are driving investments into the sector.

Investing in healthcare, whether through pharmaceutical companies, biotech firms, or health tech startups, provides a balanced approach to capitalizing on a sector with a strong growth outlook and essential societal role.

Of course, diversification is always the investor’s best strategy to position themselves to mitigate risk and seize opportunities, but these three sectors in particular offer compelling reasons for consideration for the rest of the year.

(Author is CEO and Founder, deVere Group)

Disclaimer: Views, recommendations, opinions expressed are personal and do not reflect the official position or policy of FinancialExpress.com. Readers are advised to consult qualified financial advisors before making any investment decision. Reproducing this content without permission is prohibited.